poisar

Stocks · News reference

Cycurion Requests Nasdaq Hearings Panel Review Of Delisting Determination, Hearing Scheduled For August 2026

BenzingaJul 22, 2026, 1:02 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 22, 2026, 1:02 PM
Checked
Jul 22, 2026, 1:02 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncAug 26, 2026, 5:00 PML. Kevin Kelly, Chairman And Chief Executive Officer

    Cycurion: 1-for-8 Reverse Split Backed by Stronger Fundamentals

    Cycurion announced a 1-for-8 reverse stock split effective August 28, 2026, to meet listing requirements. The company reported significant operational improvements including gross margin expansion from 6.1% to 29.1% year-over-year, net debt reduction of over 50%, two strategic acquisitions, a $54.6 million HHS contract, and $15-17 million in firmly committed annual recurring revenue through 2028. CEO Kelly addressed a stock manipulation campaign and reaffirmed the company's target to achieve break-even profitability by Q2 2027.

    Read original at globenewswire-inc